دورية أكاديمية
Herbal textual research of Belamcanda chinensis (L.) redouté and screening of quality-markers based on 'pharmacodynamics-substance'.
| العنوان: | Herbal textual research of Belamcanda chinensis (L.) redouté and screening of quality-markers based on 'pharmacodynamics-substance'. |
|---|---|
| المؤلفون: | Wang Z; School of Pharmacy, Changchun University of Chinese Medicine, Jilin, Changchun, 130000, China. Electronic address: qq744233398@163.com., Jiang Y; School of Pharmacy, Changchun University of Chinese Medicine, Jilin, Changchun, 130000, China. Electronic address: 240517674@qq.com., Li Z; School of Pharmacy, Changchun University of Chinese Medicine, Jilin, Changchun, 130000, China. Electronic address: 1160946473@qq.com., Weng L; School of Pharmacy, Changchun University of Chinese Medicine, Jilin, Changchun, 130000, China. Electronic address: 735110462@qq.com., Xiao C; School of Pharmacy, Changchun University of Chinese Medicine, Jilin, Changchun, 130000, China. Electronic address: btxnw@163.com. |
| المصدر: | Journal of ethnopharmacology [J Ethnopharmacol] 2024 Oct 05; Vol. 332, pp. 118324. Date of Electronic Publication: 2024 May 14. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7573 (Electronic) Linking ISSN: 03788741 NLM ISO Abbreviation: J Ethnopharmacol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Limerick : Elsevier Sequoia Original Publication: Lausanne, Elsevier Sequoia. |
| مواضيع طبية MeSH: | Rhizome*/chemistry, Humans ; Animals ; Drugs, Chinese Herbal/pharmacology ; Drugs, Chinese Herbal/chemistry ; Medicine, Chinese Traditional ; Iridaceae/chemistry ; Ethnopharmacology/methods |
| مستخلص: | Ethnopharmacological Relevance: Belamcanda chinensis (L.) Redouté is widely distributed in East Asia, such as China, Russia and North Korea. Belamcandae Rhizoma is the sun-dried rhizome of B. chinensis and has a long history of traditional medicinal use. It was first recorded in the Shennong's Herbal Classic, and has the effects of clearing heat and detoxifying, eliminating phlegm and benefiting the pharynx. Aim of the Study: To systematically study the source of Belamcandae Rhizoma, summarize the evolution of its medicinal properties, efficacy and the application history of its prescriptions, summarize its biological activity, phytochemistry, synthetic metabolic pathway and toxicology, and screen the Quality-Markers of Belamcandae Rhizoma according to the screening principle of traditional Chinese medicine Quality-Markers. Materials and Methods: All information available on Belamcandae Rhizoma was collected using electronic search engines, such as Pubmed, Web of Science, CNKI, WFO (www.worldfloraonline.org), MPNS (https://mpsn.kew.org), Changchun University of Traditional Chinese Medicine Library collections, Chinese Medical Classics. Results: The source of Belamcandae Rhizoma is B. chinensis of Iridaceae. It has a long history of application in China. It has the effects of clearing heat and detoxifying, eliminating phlegm and promoting pharynx. Modern pharmacological studies have shown that it has anti-inflammatory, anti-oxidation, anti-tumor and other physiological activities, and is safe and non-toxic at normal application doses. At present, tectoridin, iridin, tectorigenin, irigenin and irisflorentin are identified as the Quality-Markers of Belamcandae Rhizoma. Conclusions: As a traditional Chinese medicine, Belamcandae Rhizoma has a long history of application, and multifaceted studies have demonstrated that Belamcandae Rhizoma is a promising Chinese medicine with good application prospects. By reviewing and identifying the Quality-Markers of Belamcandae Rhizoma, this study can help to establish the evaluation procedure of it on the one hand, and identify the shortcomings research on the other hand. Currently, there are few studies on the anabolism and toxicology of it, and future studies may focus on its in vivo processes, toxicology and adverse effects. Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2024 Elsevier B.V. All rights reserved.) |
| فهرسة مساهمة: | Keywords: Belamcandae rhizoma; Ethnopharmacology; Pharmacology; Phytochemistry; Quality-markers |
| المشرفين على المادة: | 0 (Drugs, Chinese Herbal) |
| تواريخ الأحداث: | Date Created: 20240516 Date Completed: 20240611 Latest Revision: 20240612 |
| رمز التحديث: | 20240612 |
| DOI: | 10.1016/j.jep.2024.118324 |
| PMID: | 38754643 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1872-7573 |
|---|---|
| DOI: | 10.1016/j.jep.2024.118324 |